-
Novavax's new COVID vaccine cleared for use by FDAAn updated COVID-19 vaccine made by Novavax has been authorized by the FDA, joining the two vaccines already cleared for use.
-
Nobel Prize in medicine goes to scientists who paved the way for COVID-19 mRNA vaccinesKatalin Karikó and Dr. Drew Weissman won the 2023 Nobel Prize in medicine for their work on mRNA vaccines.
-
COVID drug molnupiravir may be driving the virus to mutate — should we worry?The antiviral molnupiravir may be shaping the evolution of the virus behind COVID-19, but we still don't know what this means for transmission or the emergence of variants.
-
Brain fog in long COVID may be linked to blood clotsA new study links long-COVID-related brain fog to two blood-clotting proteins.
-
Coronavirus variants: Facts about omicron, delta and other SARS-CoV-2 mutantsHere's a look at the science behind SARS-CoV-2 variants, including the now-dominant omicron and its many defunct relatives.
-
COVID subvariant EG.5 and its spawn 'Eris' now dominant in the USAn omicron subvariant called EG.5 has become the most prevalent version of SARS-CoV-2 in the U.S. by a narrow margin, according to CDC estimates.
-
'Excess deaths' tied to COVID have plummeted in America — what does that mean?Data shows that America's excess death rates have mostly returned to pre-pandemic levels, reflecting the end of the public health crisis, experts say.
-
Genetic quirk could explain why not everyone shows symptoms of COVID-19In a large cohort of people infected with SARS-CoV-2, a specific gene variant was more common in people who didn't show symptoms, compared to those who did.
-
Declassified US intelligence report finds no evidence of coronavirus 'lab leak' from Wuhan instituteA declassified U.S. intelligence report further refutes the idea that SARS-CoV-2 "leaked" from the Wuhan Institute of Virology.
